A 49-year-old womanwith Cushing's syndrome due to unilateral adrenal hyperplasia is presented. She had developed obesity and menopause for 2 years, but no hypertension or hypertrichosis was observed. Although plasma adrenocorticotropin and serum cortisol levels were within normal ranges, the circadian rhythm has completely disappeared. Free thyroxine and triiodothyronine levels were decreased. Adrenocorticotropin did not respond to corticotropinreleasing hormone, and urinary excretion of 17-hydroxycorticosteroids was not suppressed by dexamethasone. Abdominal computed tomography and 131I-Adosterol scintigraphy demonstrated a unilateral functioning mass in the left adrenal gland. The resected left adrenal mass was pathologically diagnosed as the rare condition of adrenocortical nodular hyperplasia. (Internal Medicine 37: 385-390, 1998) 
Introduction
Cushing's syndrome is caused by adrenocortical hypersecretion of cortisol, most of which results from adrenocortical adenoma or pituitary adenoma, i.e. Cushing's disease. The present case of Cushing's syndrome is attributable to a unilateral adrenocortical hyperplasia. This rare pathology has been documented in only 5 cases ofCushing's syndrome (1) (2) (3) (4) (5) . This case report not only introduces a clinical variety of Cushing's syndrome, but also illustrates the clinical influence of adrenal function on the thyroid.
Case Report
A 49-year-old womaninitially presented a complaint of pretibial edema in 1989. She has been free of both hypertension and diabetes, but she has suffered general fatigue and has gained 5 kg over 2 years. Menopause occurred at the age of47 years old. She was admitted to our hospital for evaluation of endocrine function in 1996. The physical examination on admission revealed the following: height, 147.9 cm; weight, 55.7 kg, featuring mild obesity with a round face; blood pressure, 136/ 80 mmHg;pulse, 75 bpm and regular. No goiter or lymphadenopathy was observed. Nostriae cutis was found on abdomen or extremities. Pretibial and pedal pitting edema were noted.
The examination findings of lung, heart and nervous system revealed nothing in particular. The laboratory examination revealed the following: white blood cell count, 9,300/|il with 15% lymphocytes and 1% eosinophils; red blood cell count, 419x104/jli1; hemoglobin, 13.5 g/dl; hematocrit, 40.6%; platelet, 3 10x103/| ll1; total protein, 6. 1 1 g/dl; serum albumin, 3.58 g/ dl; serum sodium, 144 mmol//; serum potassium, 3.9 mmol//; serum chloride, 105 mmol//, serum calcium, 8.6 mg/dl; serum inorganic phosphate, 3. 1 mg/dl; alkaline phosphatase, 107 IU/ /; creatinine phosphokinase, 73 IU//; total cholesterol, 227 mg/ dl; and triglyceride, 108 mg/dl; liver, renal functions and urinalysis were normal. Fasting blood glucose was 86 mg/dl, and hemoglobin Alc was 6.4% (normal: 4-6) . Oral glucose (75 g) tolerance test revealed an impaired glucose tolerance. The bone density in her lumbar spine (QDR-1000) was decreased to 0.609 g/cm2 (mean ± SD in a normal 49-year-old female: 0.993 + 0. 139). The endocrinological data on admission are shown in Table 1 . Free triiodothyronine (FT3) and thyroxine (FT4) concentrations were decreased, while thyrotropin (TSH) level was normal. Reverse triiodothyronine (rT3) and thyroxine binding globulin (TBG) were normal. The serum cortisol (F) concentration in the morningwas normal, and the plasma adrenocorticotropin (ACTH) obtained at the same time was at the lower limit of the normal range. hormone (TRH) was also markedly suppressed (Table 2a) . Cranial magnetic resonance imaging (MRI) demonstrated a normal pituitary. The circadian rhythm of ACTHand F was completely eliminated (Table 3a) , and the adrenal response to ACTHinjection (0.25 mg) was impaired. Administration of 1 mg dexamethasone did not suppress serum F level, and the suppression test using 2 or 8 mg dexamethasone revealed a paradoxic increase of urinary 17-OHCS (Table 4) . A left adrenal mass was discovered on abdominal computed tomography (CT; Fig. 1A ), while no nodular formation was detected in right adrenal gland (Fig. IB) . The 131I-Adosterol scintigraphy exhibited a fine accumulation in the left adrenal mass, in contrast to no accumulation in the right adrenal gland (Fig. 2) . Because the diagnosis of Cushing's syndrome was confirmed, left adrenalectomy was performed on July 23, 1996.
Histological examination of the resected mass was consistent with adrenal macronodular hyperplasia, predominantly consisting of compact cells (Fig. 3) . Following adrenalectomy, intravenous administration of hydrocortisone (100 to 50 mg/ day) was initiated for 3 days, and oral administration with 25 mg/day ofhydrocortisone has been maintained. One week after the surgery, serum F change in a day has taken the form of a Abbreviations and normal values are shown in Table 1 . (Table 3b) , and both FT3 and FT4 concentrations were also normalized. Serum TSH level has gradually increased, and reached the peak on day 8 after surgery, and consequently decreased to within the normal limit (Fig. 4) . Three months after the surgery, ACTH and TSHresponses to CRHand TRH, respectively, became normal, while prolactin (PRL) response to TRHwas augmented compared with the preoperative one. Serum F response to CRH was impaired, reflecting the right adrenal suppression (Table  2b ). One year after the surgery, she has been maintained with 5 mg/day of hydrocortisone, and her clinical symptomsdue to hypercortisolemia have completely disappeared.
Discussion
The present case is a rare pathologic variety of Cushing's syndrome, which has been diagnosed as a unilateral adrenal adenoma before the surgery.
In this case, the basal endocrinological data was not adequate for the diagnosis of Cushing' s syndrome, because both serum F and plasma ACTH have been within the normal ranges. Taking the periodic hypersecretion of F into consideration (6, 7) , it is quite difficult to prove the clinical hypercortisolemia. The diagnosis for Cushing's syndromehence requires repeated endocrinological ob- servations including stimulation or suppression tests. In the present case, the symptoms due to hypercortisolemia seemed to manifest at the age of 47, whenthe patient's menopauseand weight gain appeared gradually. Furthermore, the lack ofACTH elevation induced by CRHand the disappearance of circadian rhythm in serum F disclosed the autonomoussecretion of F. This phenomenonwas also confirmed by the dexamethasone ( Figure 4 . Clinical course. Left adrenalectomy was performed on July 23, 1996. After the surgery, the patient was given hydrocortisone (100 to 50 mg/day) intravenously, followed by the oral administration of 25 mg/day. Both the free triiodothyronine (FT3) and thyroxine (FT4) concentrations normalized on 1 week after the surgery. The serum thyrotropin (TSH) level showed a gradual increase, and reached a peak on postoperative day 8, and eventually decreased to within the normal limit.
consisting of compact cells, and non-atrophic findings in the perinodular region (10) . The nodular hyperplasia in this case was distinguished from ACTH-independent macronodular hyperplasia (AIMAH) or primary pigmented nodular adrenocortical disease (PPNAD), because of the marked laterality of the adrenal gland in radiographic findings. Although the Cushing' s cases of unilateral adrenal hyperplasia dependent upon ACTH have been occasionally reported in pituitary or ectopic ACTH producing tumors (1 1-15), there have been only 5 cases well documented on Cushing' s syndrome due to ACTH-independent unilateral adrenal hyperplasia (1) (2) (3) (4) (5) . The marked adrenocortical laterality and the improvement of Cushing' s syndrome after hemiadrenalectomy suggest that the adrenocortical hyperplasia in the present case mayhave similar characteristics to adenomas. However, in the cases of hyperplasia, the remained adrenal gland should be carefully observed for a long period after surgery, paying attention to the morphological or hor- (19, 20) . These phenomena have also been reported in Cushing's syndrome (21-23). Amongthese, the present case demonstrated a decreased FT3 and FT4 as well as a blunted response of TSHto TRHpreoperatively. In contrast, rapid increases of FT3 and FT4 have followed the left adrenalectomy with replacement therapy, and the serum TSHlevel also eventually normalized. The recovery of thyroid dysfunction after adrenalectomy suggests that the preoperative hypothyroidism was affected by the hypercortisolemia which might induce both the inhibition of peripheral conversion of T4 to T3 and the blunted secretion of TSH (16) (17) (18) (19) . Although the interrelationship between the pituitary excretion of PRL and glucocorticoid is controversial (16-18), the PRLresponse to TRHwas also augmented under the corrected adrenal state in the present case.
The physiological glucocorticoid level is likely required to maintain these pituitary and thyroid functions.
In conclusion, we presented a very rare case of Cushing's syndrome due to unilateral adrenocortical nodular hyperplasia. The accumulation of reports concerning the clinical characteristics of the same pathology may be helpful for resolving the pathophysiology of this disease.
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